NCT04000633

Nebulized Lidocaine to Prevent Cough at Emergence From Anesthesia

Nebulized Lidocaine Versus Placebo to Prevent Cough at Emergence From Anesthesia: a Double Blind Prospective Randomised Trial

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 80 (estimated)
• Sponsor: Mongi Slim Hospital · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

our study aimed to evaluate the effect of nebulized lidocaine to decrease the incidence of cough and sore throat after extubation after surgeries requiring endotracheal intubation.

Detailed description

our study aimed to evaluate the effect of nebulized lidocaine to decrease the incidence of cough and sore throat after extubation after surgeries requiring endotracheal intubation. This randomized controlled study will compare the effect of Lidocaine and placebo nebulization in the immediate pre operative period in order to evaluate the effectiveness in reducing post extubation cough and sore throat.

Conditions

• Cough, General Anesthesia, Extubation, Lidocaine, Sore Throat

Interventions

Type	Name	Description
DRUG	Lidocaine 2%	the patients of this group will recieve nebulization of 5 ml of 2% lidocaine prior to induction of general anesthesia
DRUG	Normal saline	Normal saline

Timeline

• Start date: 2019-06-01
• Primary completion: 2019-12-31
• Completion: 2019-12-31
• First posted: 2019-06-27
• Last updated: 2019-06-27

Locations

1 site across 1 country: Tunisia